1. PURPOSE
To establish a standardized Procedural Sedation Program that ensures safe, consistent, and high-quality care for patients receiving minimal, moderate, or deep procedural sedation across all approved hospital locations through defined governance, privileging and competency requirements, pre-sedation assessment, monitoring standards, medication safety, recovery and discharge criteria, adverse event management and reporting, and pediatric-specific safeguards where applicable, consistent with CBAHI perioperative safety expectations for standardized processes, consent, checklists, medication reconciliation, and safe discharge after sedation. (istitlaa.ncc.gov.sa)
2. SCOPE
This policy applies to all procedural sedation delivered in the hospital by anesthesia professionals and by non-anesthesia practitioners who are credentialed and privileged to provide sedation under hospital rules, in all approved locations including (but not limited to): Emergency Department procedure rooms, Endoscopy, Interventional Radiology, Cardiac Catheterization, CT/MRI suites, bronchoscopy suites, outpatient procedure areas, minor procedure rooms, and any other approved sedation sites.
This policy applies to: sedation providers (physicians/dentists/qualified practitioners), anesthesia professionals when involved, proceduralists, sedation monitors (nursing/clinical staff assigned to continuous monitoring), recovery nurses, pharmacists, and quality/patient safety personnel supporting the program.
3. DEFINITIONS
3.1 Levels of Sedation (Continuum)
- Minimal sedation (anxiolysis): Normal response to verbal stimulation; airway and ventilation unaffected; cardiovascular function unaffected.
- Moderate sedation: Purposeful response to verbal commands (with or without light tactile stimulation); airway intervention not required; spontaneous ventilation adequate; cardiovascular function usually maintained.
- Deep sedation: Purposeful response after repeated or painful stimulation; ability to maintain airway may be impaired; spontaneous ventilation may be inadequate; cardiovascular function usually maintained.
- General anesthesia: Unarousable even with painful stimulation; airway intervention often required; ventilation often inadequate; cardiovascular function may be impaired.
(Definitions consistent with widely used sedation continuum concepts embedded in major sedation standards and hospital sedation procedures.) (aspho.org)
3.2 Sedation Provider (Sedationist)
A practitioner credentialed and privileged to administer procedural sedation within defined limits, and capable of recognizing progression to a deeper level and performing rescue interventions appropriate to the setting and intended sedation depth. (asahq.org)
3.3 Sedation Monitor
A trained staff member assigned to continuous patient monitoring during sedation and early recovery, with authority to stop the procedure and activate escalation when patient safety criteria are not met.
3.4 Approved Sedation Location
A location formally approved for procedural sedation through an institutional readiness process verifying minimum equipment, staffing, monitoring, medications (including reversal agents), and emergency response capability. (publicshare.albertahealthservices.ca)
3.5 Rescue Capability
Ability to identify deterioration and intervene to restore airway patency, support ventilation/oxygenation, and provide circulatory support, including activation of emergency response and transfer to higher level of care.
4. POLICY
4.1 Governance (E1)
- 4.1.1 The hospital shall maintain an organized Procedural Sedation Program with defined oversight, including approved locations, standardized clinical processes, documentation requirements, staff training, audits, and performance improvement. (istitlaa.ncc.gov.sa)
- 4.1.2 Sedation services may be delivered only in locations approved through the program’s site readiness process. (publicshare.albertahealthservices.ca)
- 4.1.3 The program shall maintain a sedation adverse event registry and review events to drive system improvement. (istitlaa.ncc.gov.sa)
4.2 Privileging and Competency (E2)
- 4.2.1 No practitioner shall administer procedural sedation unless credentialed and privileged for the requested sedation level, patient population, and approved location(s). (asahq.org)
- 4.2.2 Privileges shall be granted by sedation level (minimal/moderate/deep), and may be restricted by age group (adult/pediatric), ASA class, procedure type, medication class (e.g., propofol), and location (e.g., MRI). (asahq.org)
- 4.2.3 Practitioners privileged for moderate sedation must be capable of rescuing patients who enter deep sedation; practitioners privileged for deep sedation must be capable of managing the transition toward general anesthesia risk and providing advanced rescue, consistent with ASA privileging statements. (asahq.org)
- 4.2.4 Competency validation shall occur at onboarding and at least annually and include assessment of airway support skills, recognition/management of sedation complications, medication safety, monitoring standards, and documentation. (publicshare.albertahealthservices.ca)
4.3 Pre-Sedation Assessment (E3)
- 4.3.1 A documented pre-sedation assessment shall be completed for every sedation episode and updated on the day of procedure. (publicshare.albertahealthservices.ca)
- 4.3.2 Pre-sedation assessment shall include history, physical examination, ASA class, airway and aspiration risk screen, NPO/fasting status (when applicable), baseline vitals, medication reconciliation, allergy verification, and an individualized sedation plan. (publicshare.albertahealthservices.ca)
4.4 Sedation Monitoring (E4)
- 4.4.1 Monitoring shall match sedation depth and patient risk and include continuous observation, documented vital signs at defined intervals, continuous pulse oximetry, and additional monitoring (ECG/capnography) when indicated. (publicshare.albertahealthservices.ca)
- 4.4.2 For deep sedation (or when deep sedation is targeted or occurs), end-tidal CO₂ monitoring (capnometry/capnography) shall be used when available and not precluded by the procedure/equipment, consistent with established sedation procedures and major guidelines. (publicshare.albertahealthservices.ca)
- 4.4.3 The patient shall remain under continuous line-of-sight observation by trained staff during active sedation and early recovery, with the sedation monitor empowered to halt the procedure for safety. (rch.org.au)
4.5 Medications and Reversal Agents (E5)
- 4.5.1 Sedation medications shall be stored, prepared, labeled, administered, and documented according to medication safety standards, including segregation of high-alert medications and availability of reversal agents when indicated. (publicshare.albertahealthservices.ca)
- 4.5.2 Reversal agents (e.g., naloxone and flumazenil) shall be immediately available in all locations where opioid and benzodiazepine sedation is administered, with clear dosing guidance and escalation requirements. (publicshare.albertahealthservices.ca)
4.6 Recovery and Discharge (E6)
- 4.6.1 Patients shall be monitored in recovery until they return to baseline level of consciousness and meet predefined discharge criteria; discharge must be safe and appropriately authorized. (rch.org.au)
- 4.6.2 Written discharge criteria shall exist for recovery from moderate/deep sedation, and discharge to unit/home must follow approved criteria and appropriate authorization and instructions, consistent with CBAHI sedation discharge requirements. (istitlaa.ncc.gov.sa)
4.7 Adverse Events and Reporting (E7)
- 4.7.1 All sedation adverse events and near-misses shall be documented, managed according to clinical severity, and reported through the institutional incident reporting process and sedation program registry. (publicshare.albertahealthservices.ca)
- 4.7.2 Escalation and rescue processes shall be immediately activated for apnea, airway obstruction, laryngospasm, aspiration, hemodynamic instability, allergic reactions, or unexpected deepening of sedation. (publicshare.albertahealthservices.ca)
4.8 Pediatric Procedural Sedation (E8)
- 4.8.1 When pediatric procedural sedation is performed, it shall follow pediatric-specific assessment, monitoring, medication, staffing, and discharge safeguards, including continuous observation, age-appropriate sedation scoring, and return-to-baseline discharge criteria. (rch.org.au)
5. PROCEDURES
5.1 E1 — Sedation Governance (Oversight, Approved Locations, Audit)
5.1.1 Sedation Program Oversight Structure
- a) The hospital shall designate a Sedation Program Lead (medical) and Sedation Program Coordinator (clinical/quality) responsible for program implementation, maintenance, and reporting.
- b) A Sedation Oversight Group (or committee) shall meet at a defined frequency (at least quarterly) and include representation from: anesthesia, procedural services (endoscopy/IR/cath/ED as applicable), nursing, pharmacy, quality/patient safety, and biomedical engineering as required.
- c) The Sedation Oversight Group shall approve: sedation locations, sedation privilege pathways, standardized documentation tools, monitoring requirements, emergency readiness standards, and audit plans.
5.1.2 Approved Sedation Locations (Site Readiness Process)
- a) Sedation may be performed only in approved locations.
- b) Each sedation location shall undergo initial approval and periodic re-approval (at least annually) verifying minimum readiness requirements consistent with safe sedation practices. (publicshare.albertahealthservices.ca)
- c) Minimum readiness requirements include:
- Oxygen source and delivery devices appropriate for adults/pediatrics as applicable.
- Suction, functioning and immediately accessible.
- Bag-valve-mask with appropriate sizes; airway adjuncts (oropharyngeal/nasopharyngeal airways); basic airway equipment.
- Advanced airway access pathway (equipment availability in location or immediate access plan), and immediate escalation capability.
- Monitoring equipment: pulse oximetry, blood pressure, ECG capability when indicated, capnography capability where required/available for deep sedation. (publicshare.albertahealthservices.ca)
- Emergency cart/defibrillation access with defined response time.
- Medication storage compliant with safety standards, including reversal agents availability. (publicshare.albertahealthservices.ca)
- Recovery area with monitoring capability and trained staff to observe until discharge criteria are met. (rch.org.au)
- Communication: reliable call system for anesthesia/rapid response/code blue.
- Transfer pathway to higher acuity care (PACU/ICU/ED resuscitation area) when required.
5.1.3 Standardized Sedation Documentation Tools
- a) The program shall provide standardized forms/electronic templates:
- Pre-sedation assessment and sedation plan
- Intra-sedation monitoring record
- Medication administration record with time/dose/route
- Adverse event documentation
- Recovery and discharge record
- b) Documentation shall be sufficient to record evaluation, plan, drugs administered, depth of sedation, monitoring data, adverse events, and interventions. (chi.gov.sa)
5.1.4 Audit and Quality Improvement
- a) The program shall define KPIs and audit sampling methodology.
- b) Minimum audit indicators include:
- Completion of pre-sedation assessment elements (ASA, airway, fasting, baseline vitals) (publicshare.albertahealthservices.ca)
- Monitoring compliance (frequency and parameters; capnography use where applicable) (publicshare.albertahealthservices.ca)
- Documentation completeness (medications, vitals, sedation depth score, events) (chi.gov.sa)
- Discharge criteria documentation and authorization (moderate/deep sedation) (istitlaa.ncc.gov.sa)
- Adverse event rate and event classification (apnea, desaturation, hypotension, aspiration) (publicshare.albertahealthservices.ca)
- c) Audit results and trends shall be reviewed by the Sedation Oversight Group and used to implement corrective actions (training, process redesign, resource upgrades).
5.2 E2 — Sedation Privileging (Who Can Do What Level; Competency Requirements)
5.2.1 Privilege Categories
Sedation privileges shall be defined by:
- a) Sedation level: Minimal / Moderate / Deep
- b) Patient age group: Adult / Pediatric (where applicable)
- c) Location category: ED / Endoscopy / IR / Cath Lab / CT / MRI / outpatient procedural areas
- d) Medication class restrictions (e.g., propofol, ketamine) per institutional rules
- e) Patient risk limitations (ASA class, OSA/high-risk airway, significant comorbidities)
5.2.2 General Privileging Principles
- a) Privileges shall be granted only after verified training, competence, and ongoing evaluation consistent with ASA privileging statements for moderate and deep sedation. (asahq.org)
- b) Practitioners administering moderate sedation must be capable of rescuing patients who enter deep sedation, including airway support and ventilation with bag-mask. (asahq.org)
- c) Deep sedation privileges for non-anesthesiologist physicians shall be restricted and granted only when the practitioner demonstrates competency consistent with deep sedation privilege expectations, due to the risk of transition to general anesthesia. (asahq.org)
5.2.3 Minimum Competency Requirements (All Sedation Providers)
- a) Knowledge of sedation pharmacology for permitted drugs and antagonists/reversal agents. (asahq.org)
- b) Ability to perform pre-sedation assessment (ASA class, airway and aspiration risk, fasting considerations, medication/allergy review). (publicshare.albertahealthservices.ca)
- c) Proficiency in monitoring interpretation and early recognition of deterioration. (publicshare.albertahealthservices.ca)
- d) Skills to provide rescue interventions appropriate to sedation level, including airway opening maneuvers, suction, oxygen delivery, bag-mask ventilation, and activation of emergency response. (asahq.org)
- e) Competence in documentation requirements, including sedation depth scoring and event documentation. (chi.gov.sa)
5.2.4 Minimum Competency Requirements (Sedation Monitor)
- a) Continuous line-of-sight observation and accurate monitoring documentation. (rch.org.au)
- b) Recognition of airway obstruction, apnea/hypoventilation, desaturation, hypotension, and altered responsiveness. (publicshare.albertahealthservices.ca)
- c) Immediate escalation and initiation of basic rescue steps.
5.2.5 Privileging Process
- a) Privileges shall be granted through the hospital credentialing/privileging system.
- b) Initial privileges require documented completion of program-required training and competency assessment.
- c) Focused evaluation (proctoring/FPPE) shall be required for new sedationists, new locations, new patient population (pediatric), or new medication class. (asahq.org)
- d) Renewal requires ongoing practice evaluation including case volume, audit compliance, adverse event review, and continuing education.
5.3 E3 — Pre-Sedation Assessment (Hx/PE, ASA Class, Airway Screen, NPO, Baseline Vitals)
5.3.1 Timing
- a) The pre-sedation assessment shall be completed before administering sedatives/analgesics and updated on the day of procedure. (publicshare.albertahealthservices.ca)
- b) For urgent/emergent procedures, assessment shall be performed to the extent feasible and documented with the risk-benefit rationale.
5.3.2 Minimum Required Elements (Adult and Pediatric as Applicable)
- a) Patient identification and procedure confirmation.
- b) Relevant history: comorbidities, prior sedation/anesthesia complications, OSA risk, pregnancy status when applicable, recent illness (especially respiratory infection in children), and fasting/aspiration risk factors. (publicshare.albertahealthservices.ca)
- c) Medication reconciliation: current medications including OTC/herbal; anticoagulants/antiplatelets as relevant; substance use when relevant; chronic opioids/sedatives. (istitlaa.ncc.gov.sa)
- d) Allergies and reaction type (including latex/chlorhexidine where relevant).
- e) Focused physical exam: airway, cardiopulmonary status, baseline neurologic status. (publicshare.albertahealthservices.ca)
- f) Baseline vital signs: HR, BP, RR, SpO₂, temperature when clinically indicated; weight in kg for pediatric dosing. (rch.org.au)
- g) ASA physical status classification documented for all sedation cases. (publicshare.albertahealthservices.ca)
- h) Airway and aspiration risk screening: mouth opening, neck mobility, dentition, previous difficult airway, OSA, obesity, reflux/vomiting/bowel obstruction, pregnancy, and procedure positioning limitations. (aspho.org)
- i) NPO/fasting status assessed and documented when applicable; urgent cases proceed based on clinical urgency with risk mitigation documented. (المعهد الوطني للمعلومات الحيوية)
- j) Planned sedation level, intended medications, monitoring plan, recovery plan, and rescue plan documented. (chi.gov.sa)
- k) Informed consent documented for sedation as required by hospital policy. (وزارة الصحة السعودية)
5.3.3 Patient Selection and Exclusion (Minimum Program Rules)
- a) Patients with high-risk features (e.g., anticipated difficult airway, severe OSA, hemodynamic instability, significant respiratory compromise, high ASA class, inability to cooperate when required) require escalation to anesthesia service or higher-level sedation pathway as defined by the hospital program. (asahq.org)
- b) Pediatric sedation requires additional screening for age-specific risks and recent illness, and must follow pediatric safeguards. (rch.org.au)
5.4 E4 — Sedation Monitoring (Line of Sight, Vitals, SpO₂, ECG When Indicated, Capnography Where Required/Available)
5.4.1 Monitoring Roles and Line-of-Sight
- a) Continuous direct observation (line-of-sight) of the patient is required during active sedation and early recovery. (rch.org.au)
- b) A dedicated sedation monitor shall be assigned according to sedation depth and patient risk, and shall not be concurrently responsible for performing the procedure in moderate/deep sedation cases where patient safety would be compromised. (asahq.org)
5.4.2 Minimum Monitoring Parameters
- a) Oxygenation: Continuous pulse oximetry. (aspho.org)
- b) Ventilation: Continuous assessment of respiratory rate and effort; use capnography for deep sedation where available/not precluded; consider capnography to supplement standard monitoring in moderate sedation according to guideline recommendations and local capability. (publicshare.albertahealthservices.ca)
- c) Circulation: Heart rate and blood pressure documented at defined intervals; ECG monitoring when indicated by patient risk, medication choice, or clinical condition. (publicshare.albertahealthservices.ca)
- d) Level of consciousness/sedation depth: Use an approved sedation scale and document at defined intervals. AHS uses Ramsay Sedation Scale (RSS) with monitoring escalation for deep sedation targets. (publicshare.albertahealthservices.ca)
5.4.3 Monitoring Frequency (Minimum; Increase as Needed)
- a) Baseline vitals immediately prior to sedation drug administration.
- b) During sedation: document BP/HR/RR/SpO₂ at least every 5 minutes for moderate/deep sedation; more frequent if unstable or during high-risk periods (bolus dosing, airway manipulation). (publicshare.albertahealthservices.ca)
- c) Document sedation depth score at defined intervals (at least every 5–10 minutes) and whenever clinical status changes. (publicshare.albertahealthservices.ca)
- d) During recovery: document vitals and sedation score at least every 10–15 minutes until discharge criteria are met, and more frequently if any concern persists. (rch.org.au)
5.4.4 Capnography Requirements
- a) When deep sedation is targeted (or patient reaches deep sedation), ETCO₂ monitoring shall be used if available (capnometry/capnography) as described in established sedation procedures (e.g., RSS 5–6 deep sedation targeting). (publicshare.albertahealthservices.ca)
- b) If capnography is not available or is invalidated by procedure/equipment, the reason shall be documented and ventilation shall be monitored by continuous clinical observation with escalation thresholds clearly defined. (aspho.org)
5.4.5 NORA/MRI and Limited-Access Environments
- a) In environments with limited airway access (e.g., MRI), the sedation plan must include emergency extraction strategy, compatible monitoring equipment, and clear stop criteria. (rch.org.au)
5.5 E5 — Medication & Reversal Agents (Storage, Labeling, Readiness)
5.5.1 Medication Safety Principles
- a) Sedation medications shall be treated as high-risk medications when capable of producing deep sedation or respiratory depression; preparation and administration must follow strict labeling and verification. (aspho.org)
- b) Syringes and infusion lines shall be labeled immediately after preparation, including drug name, concentration, and preparer identity where required by institutional policy.
- c) Storage shall comply with pharmacy policy, controlled drug requirements, and temperature/light protection instructions.
5.5.2 Standard Medication Availability by Sedation Level
- a) Minimal/moderate sedation: authorized sedative/analgesic agents per formulary, with rescue and reversal agents available as applicable. (aspho.org)
- b) Deep sedation: additional airway rescue readiness and immediate access to resuscitation medications and equipment appropriate to the elevated risk of progression to general anesthesia. (asahq.org)
5.5.3 Reversal Agents
- a) Naloxone shall be available wherever opioids are used for sedation/analgesia. (publicshare.albertahealthservices.ca)
- b) Flumazenil shall be available wherever benzodiazepines are used for sedation. (publicshare.albertahealthservices.ca)
- c) Reversal agent dosing guidance shall be available at point of care (cognitive aid/poster or embedded in the sedation record).
- d) After reversal agent administration, the patient shall remain under extended observation per protocol due to re-sedation risk, with clear documentation and discharge delay as indicated. (aspho.org)
5.5.4 Oxygen and Suction
- a) Oxygen and suction must be immediately functional prior to administering sedation. (publicshare.albertahealthservices.ca)
5.6 E6 — Recovery & Discharge After Sedation (Return to Baseline; Discharge Scoring/Criteria)
5.6.1 Recovery Location and Monitoring
- a) After sedation, patients shall recover in a designated recovery area (PACU or approved sedation recovery area) with monitoring and trained staff until discharge criteria are met. (rch.org.au)
- b) Continuous observation and monitoring shall continue until the patient is no longer at risk for respiratory depression and has returned toward baseline, with vital signs within acceptable limits. (chi.gov.sa)
5.6.2 Discharge Criteria (Moderate/Deep Sedation) — Minimum Requirements
Written discharge criteria shall include, at minimum:
- a) Return to baseline level of consciousness appropriate for patient age and pre-sedation status. (rch.org.au)
- b) Stable airway patency without repeated interventions.
- c) Adequate ventilation and oxygenation for the planned destination (room air or prescribed oxygen), with stable trend.
- d) Hemodynamic stability (HR/BP acceptable for baseline and clinical context).
- e) Pain, nausea/vomiting, and other symptoms controlled with a documented plan.
- f) No ongoing bleeding or procedure complications requiring higher level of observation.
- g) Discharge instructions completed and communicated (unit instructions or home instructions). (istitlaa.ncc.gov.sa)
5.6.3 Discharge Authorization and Follow-Up Instructions
- a) Discharge after moderate/deep sedation shall be performed according to written criteria and authorized by a qualified physician, consistent with CBAHI sedation discharge requirements. (istitlaa.ncc.gov.sa)
- b) When the patient is discharged back to a unit, the physician shall provide follow-up instructions for nurses. (istitlaa.ncc.gov.sa)
- c) When the patient is discharged home, discharge shall occur with a responsible adult caregiver when required by policy, and written discharge instructions and follow-up care guidance shall be provided prior to discharge. (istitlaa.ncc.gov.sa)
5.6.4 Discharge Scoring/Tools
- a) The program shall adopt and standardize a discharge scoring system or discharge criteria checklist appropriate to patient population and location.
- b) Pediatric services shall use pediatric-appropriate sedation scoring and discharge criteria consistent with pediatric guidance. (rch.org.au)
5.6.5 Criteria for Escalation/Unplanned Admission
- a) Persistent hypoxemia, recurrent apnea/obstruction, hemodynamic instability, prolonged altered consciousness, uncontrolled pain/PONV, suspected aspiration, or any serious adverse event requires escalation to anesthesia/rapid response and consideration of admission/ICU transfer. (aspho.org)
5.7 E7 — Sedation Adverse Events (Apnea, Aspiration, Hypotension) + Reporting
5.7.1 Adverse Event Definitions (Program Standard)
Adverse events include (not limited to):
- a) Apnea or hypoventilation requiring intervention (stimulation, airway maneuvers, assisted ventilation).
- b) Oxygen desaturation below defined threshold requiring intervention.
- c) Airway obstruction requiring repeated maneuvers, airway adjunct, CPAP/NIV, or assisted ventilation.
- d) Laryngospasm/bronchospasm.
- e) Aspiration or suspected aspiration.
- f) Hypotension or bradycardia requiring vasoactive therapy or fluid bolus beyond routine.
- g) Unplanned advanced airway placement or re-intubation.
- h) Need for unplanned higher level of care transfer (PACU/ICU).
- i) Allergic reaction/anaphylaxis.
(Aligned with commonly tracked procedural sedation safety outcomes and standard program reporting expectations.) (aspho.org)
5.7.2 Immediate Clinical Response (Core Rescue Steps)
- a) Stop sedative administration and stop procedure if needed for rescue.
- b) Call for help; activate escalation (anesthesia/rapid response/code) based on severity.
- c) Airway maneuvers, suction, oxygen; jaw thrust/chin lift; appropriate positioning.
- d) Assist ventilation with bag-mask if needed; apply CPAP/NIV when appropriate and available.
- e) Treat hypotension/bradycardia per protocol; consider causes including medication effect, bleeding, vagal response.
- f) Administer reversal agents when indicated and safe, with documentation and extended monitoring. (aspho.org)
- g) Manage aspiration suspicion with airway protection strategy and escalation to higher level of care based on clinical status.
5.7.3 Documentation and Reporting
- a) Document event timeline, sedation depth at event, monitoring values, interventions, response, and final disposition. (chi.gov.sa)
- b) Report adverse events through the institutional reporting system and Sedation Program registry for review and improvement. (istitlaa.ncc.gov.sa)
5.7.4 Post-Event Review
- a) Serious events require multidisciplinary review (sedation oversight group) and corrective actions including training, equipment changes, privileging review, or workflow redesign.
5.8 E8 — Pediatric Procedural Sedation (If Applicable)
5.8.1 Pediatric-Specific Governance and Limits
- a) Pediatric sedation shall be delivered only by practitioners privileged for pediatric sedation and in approved pediatric-capable locations with pediatric-appropriate equipment and medications. (rch.org.au)
- b) Pediatric sedation plans shall consider developmental stage, cooperation, procedure type, fasting/aspiration risk, and higher vulnerability to airway obstruction and respiratory events.
5.8.2 Pediatric Pre-Sedation Assessment
- a) Include pediatric weight (kg) for dosing; baseline behavior/neurologic state; recent URTI and respiratory symptoms; prematurity history; OSA risk; and age-specific airway considerations. (rch.org.au)
- b) Use pediatric sedation scoring and monitoring requirements as per pediatric guidance.
5.8.3 Pediatric Monitoring and Sedation Depth Assessment
- a) Maintain continuous line-of-sight observation; use a pediatric sedation scale such as UMSS and document at defined intervals during sedation and recovery. (rch.org.au)
- b) Ensure monitoring consistent with sedation depth and risk; consider ETCO₂ monitoring for deep sedation when available and appropriate. (publicshare.albertahealthservices.ca)
5.8.4 Pediatric Recovery and Discharge
- a) Discharge criteria include return to baseline consciousness and stable observations within normal limits for age, consistent with pediatric sedation guidance. (rch.org.au)
- b) Discharge home requires caregiver education, written instructions, and confirmation of responsible adult supervision. (istitlaa.ncc.gov.sa)
6. RESPONSIBILITIES
6.1 Sedation Provider
- Completes and documents pre-sedation assessment, ASA class, sedation plan, and consent where required. (publicshare.albertahealthservices.ca)
- Ensures appropriate monitoring, staffing, equipment readiness, and rescue capability before drug administration. (publicshare.albertahealthservices.ca)
- Administers medications within granted privileges and documents drugs, timing, and patient response. (chi.gov.sa)
- Responds to adverse events and escalates appropriately. (aspho.org)
- Authorizes discharge as required by policy for moderate/deep sedation discharge criteria. (istitlaa.ncc.gov.sa)
6.2 Sedation Monitor
- Maintains continuous line-of-sight observation; documents monitoring values and sedation depth at required intervals; initiates rescue steps and calls for help at the earliest sign of deterioration. (rch.org.au)
6.3 Proceduralist/Surgical Team
- Ensures procedure readiness, communicates procedural requirements/risks, participates in safety checks, and coordinates with sedation provider for stop criteria and escalation.
6.4 Recovery Nurse/Recovery Area Staff
- Monitors recovery, documents discharge criteria, manages symptoms per orders, escalates deterioration, and ensures discharge instructions are provided.
6.5 Pharmacy
- Ensures sedation medication availability, safe storage, labeling standards, controlled drug processes, and reversal agents availability. (chi.gov.sa)
6.6 Quality/Patient Safety
- Supports audits, adverse event review, KPI reporting, and improvement actions.
8. COMPLIANCE AND AUDIT
The Sedation Program shall monitor compliance through periodic audits and KPI reporting, including:
- Pre-sedation assessment completeness and ASA documentation rate. (publicshare.albertahealthservices.ca)
- Monitoring compliance (frequency; SpO₂ continuous; ETCO₂ use for deep sedation where available). (publicshare.albertahealthservices.ca)
- Medication labeling and reversal agent readiness compliance. (publicshare.albertahealthservices.ca)
- Discharge criteria documentation and qualified physician discharge authorization for moderate/deep sedation recovery. (istitlaa.ncc.gov.sa)
- Adverse event rates, severity classification, unplanned escalation transfers, and return visits. (aspho.org)
Audit findings shall result in documented corrective actions and re-audit.